Gilenya Drug Administration

Gilenya Drug Administration
Gilenya (fingolimod) 0.5 mg per day for the treatment of relapsing forms of MS by the Food and drug administration approved. Swiss pharmaceutical group Novartis said Gilenya is the first oral drug for the treatment of relapsing forms of multiple sclerosis (MS) in the U.S. indicated – it reduces the frequency of MS attacks, and taken to